NCT07494669

Brief Summary

Study combines physiological data from wearables, continuous glucose montiors and proteomics to better assess risk of complications after colorectal surgery

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
210

participants targeted

Target at P75+ for all trials

Timeline
20mo left

Started Apr 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress16%
Apr 2026Mar 2028

First Submitted

Initial submission to the registry

March 20, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 27, 2026

Completed
11 days until next milestone

Study Start

First participant enrolled

April 7, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2028

Last Updated

March 27, 2026

Status Verified

March 1, 2026

Enrollment Period

2 years

First QC Date

March 20, 2026

Last Update Submit

March 20, 2026

Conditions

ObservationPostoperative

Keywords

complicationsrisk stratificationproteomics

Outcome Measures

Primary Outcomes (1)

  • Complications (Clavien-Dindo >0)

    30 days postoperatively

Secondary Outcomes (1)

  • Serious complications

    30 days postoperatively

Interventions

Risk stratification with proteomics and data from wearables and CGMsDIAGNOSTIC_TEST

Risk Stratification

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients scheduled for elective colorectal cancer surgery

You may qualify if:

  • Scheduled for elective colorectal cancer surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Tomas Vedin, MD, PhD

CONTACT

+4640331200tomas.vedin@med.lu.se

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 20, 2026

First Posted

March 27, 2026

Study Start

April 7, 2026

Primary Completion (Estimated)

March 30, 2028

Study Completion (Estimated)

March 30, 2028

Last Updated

March 27, 2026

Record last verified: 2026-03